February 28th is Rare Disease Day , a day dedicated to raising awareness of the nearly 7,000 rare diseases affecting nearly 30 million Americans. In other words, as many as one in ten Americans are suffering from a rare disease.
Globally, rare diseases affect more than 250 Million people. [Read more on FDA's site for Rare Disease] Find out how you can support Rare Disease awareness at NORD and EURORDIS
In the U.S., a rare disease is one that affects fewer than 200,000 people. This definition comes from the Orphan Drug Act of 1983 and is slightly different from the definition used in Europe.
Besides dealing with their specific medical problems, people with rare diseases struggle to get a proper diagnosis, find information, get treatment and to connect with others like themselves. As expected, the rarity of their conditions makes everything more difficult.
With the explosive growth of the internet and social media platforms, people with rare diseases are connecting at unprecedented rates. Rare disease marketing is fast becoming the poster child for pharma's version of long-tail marketing.
Today, Susannah Fox (@SusannahFox) of the Pew Internet & American Life Project issued a report "Peer-to-Peer Healthcare" based on a national telephone survey of 3,001 people in September, 2010 and an online survey of 2,156 members of the National Organization of Rare Disorders (NORD) in December, 2010. [You can also read Wendy White's blog at Siren Interactive outlining her take on rare disease insights coming out of the Pew study.]
Some highlights:
What can Pharma and patient marketers learn from the Rare Disease Community and their love of internet connectivity and peer-to-peer healthcare?
Perhaps it comes down to this...
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Andrew Tolve explores how digital health coaching is helping the healthcare industry provide cost-effective services that boost adherence
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs